Glucagonoma differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 26: | Line 26: | ||
* A social history of the patient may indicate smoking, excessive alcohol consumption and/or a recent stressful event if life associated with an acute exacerbation of psoriasis.<sup>[[Psoriasis history and symptoms#cite note-pmid13901632-4|[4]]]</sup> | * A social history of the patient may indicate smoking, excessive alcohol consumption and/or a recent stressful event if life associated with an acute exacerbation of psoriasis.<sup>[[Psoriasis history and symptoms#cite note-pmid13901632-4|[4]]]</sup> | ||
| | | | ||
* A long-term history of [[erythematous]] scaly area, which may involve multiple areas of the body | |||
* [[Pain]], which has been described by patients as unpleasant, superficial, sensitive, itchy, hot or burning (especially in erythrodermic psoriasis and in some cases of traumatized plaques or in the joints affected by psoriatic arthritis) | |||
* [[Pruritus]] (especially in eruptive, guttate psoriasis) | |||
* High [[fever]] | |||
* Dystrophic nails | |||
* Long-term rash with recent presentation of [[arthralgia]] | |||
| | | | ||
| | * [[Papulosquamous disorder|Papulosquamous]] [[disease]] with variable morphology, distribution, severity, and course | ||
* Scaling [[Papule|papules]] and [[Plaque|plaques]] | |||
* [[Koebner phenomenon]]: appearance of new psoriatic lesions at the site of skin injury | |||
* [[Woronoff|Woronoff’s ring]]: ring of peripheral blanching skin around a psoriatic [[plaque]] | |||
* Auspitz’s sign: small [[bleeding]] points are seen upon disruption of a psoriatic scale. | |||
|'''Skin biopsy''' | |||
Perivascular and [[dermal]] [[Inflammatory cells|inflammatory cell]] infiltration | |||
[[Vascular]] dilation | |||
Absent [[granular layer]] | |||
Elongation of [[dermal]] [[Papilla|papillae]] | |||
Parakeratosis | |||
Spongiform [[pustules]] of Kogoj (pathognomic of psoriasis) | |||
Munro's micro abscesses (pathognomic of psoriasis) | |||
[[Edema]] of [[dermal]] [[papillae]] | |||
In psoriasis, skin [[biopsy]] of the affected area of skin shows that the [[Epidermis (skin)|epidermal]]/supra-papillary thickness ratio is increased | |||
[[Basal cell layer]] is expanded | |||
Leukocytosis | |||
| | | | ||
|- | |- |
Revision as of 14:45, 3 August 2017
Glucagonoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Glucagonoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Glucagonoma differential diagnosis |
Risk calculators and risk factors for Glucagonoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Glucagonoma must be differentiated from certain skin lesions (acrodermatitis enteropathica, psoriasis, pellagra, eczema) and other causes of hyperglucagonemia (infection, diabetes mellitus, Cushing syndrome, renal failure, acute pancreatitis, severe stress, and prolonged fasting).
Differentiating Glucagonoma from other Disease
Glucagonoma must be differentiated from certain skin lesions in which necrolytic migratory erythema can be found and other causes of hyperglucagonemia:[1][2]
Disease | Clinical Picture | Investigations | Pictures | ||
---|---|---|---|---|---|
History | Symptoms | Signs | |||
Glucagonoma |
|
|
|
Skin biopsy
Perivascular and dermal inflammatory cell infiltration Vascular dilation Absent granular layer Parakeratosis Spongiform pustules of Kogoj (pathognomic of psoriasis) Munro's micro abscesses (pathognomic of psoriasis) In psoriasis, skin biopsy of the affected area of skin shows that the epidermal/supra-papillary thickness ratio is increased Basal cell layer is expanded Leukocytosis |
|
End-stage liver disease | |||||
Pemphigus foliaceus | |||||
Pustular psoriasis | |||||
Acrodermatitis enteropathica | |||||
Pellagra | |||||
Chronic eczema | |||||
kwashiorkor |
References
- ↑ Glucagonoma. Wikipedia. https://en.wikipedia.org/wiki/Glucagonoma. accessed on October 10, 2015
- ↑ Fang S, Li S, Cai T (2014). "Glucagonoma syndrome: a case report with focus on skin disorders". Onco Targets Ther. 7: 1449–53. doi:10.2147/OTT.S66285. PMC 4140234. PMID 25152626.